ATLASATLAS fair value
£0.006
Above fair value · 73% premium
Range: £0.005–£0.006Fair valuePrice
BioPharma Credit (BPCR.LSE)
BioPharma Credit share price today, ATLAS forecast and fair value
Financial Services · Asset Management · London Stock Exchange · United Kingdom
£0.010▲ +0.41%
Prices as of Oct 27, 2026 · GBP
Chance of rising in 1 month
60%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on BioPharma Credit in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On BioPharma Credit
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates BioPharma Credit's fair value at about £0.006 per share (reasonable range: £0.005 to £0.006). At £0.010, the stock trades 73% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives BioPharma Credit a 60% chance of finishing higher a month from now (21 trading sessions) than today: somewhat better than a coin flip.
In half of the simulated outcomes the price ends between £0.010 and £0.010; in 9 out of 10, between £0.009 and £0.010. Estimated annual volatility is 7%.
Price, last 12 months (weekly close)
Key numbers
- P/E ratio
- 9.8
- Dividend yield
- 7.14%
- 52-week high
- £0.010
- 52-week low
- £0.009
- Revenue (12 months)
- $158M
- Operating margin
- 77.2%
- Net margin
- 82.3%
- Beta
- 0.18
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. BioPharma Credit sits above fair value and its odds of rising over a month are somewhat better than a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks BPCR.LSE has traded between £0.009 and £0.010. Today it is 2.4% below that high and 11% above its low.
On the business: net margin is 82.3%; it trades at 9.8 times earnings.
Its beta is 0.18: it tends to move less than the market.
About the company
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products.
Want to see everything about BioPharma Credit?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is BioPharma Credit (BPCR.LSE) fair value?
About £0.006 per share according to ATLAS (reasonable range: £0.005 to £0.006). With the stock at £0.010, it is 73% above it.
What is the chance BPCR.LSE goes up next month?
60%: somewhat better than a coin flip. In half of the simulated outcomes, BPCR.LSE ends the month between £0.010 and £0.010.
How big is BioPharma Credit and what is its P/E ratio?
Its price-to-earnings (P/E) ratio is 9.8: you pay £9.80 for each £1.00 of yearly earnings.
Does BioPharma Credit pay a dividend?
Yes. BPCR.LSE's current dividend yield is 7.14% at today's price (£0.010).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer